News on Hepatitis continually updated from thousands of sources around the net.
56 min ago | Hampton Roads Daily Press
In clinical trials, the polymerase inhibitor, the first used in hepatitis C treatment, has shown a more than 90 percent success rate in curing the deadly virus that causes liver failure and cancer of the liver .
Whose policies do more to help the poor?
Would you support legalizing marijuana in your state?
5 hrs ago | POZ
The U.S. Food and Drug Administration has approved Gilead Sciences' hotly anticipated Sovaldi , a once-daily oral nucleotide analog polymerase inhibitor to treat people with hepatitis C virus , including those coinfected with HIV and those who have liver cancer and are awaiting a transplant.
6 hrs ago | KXLY-TV Spokane
Sovaldi is the first drug that has been shown to safely and effectively treat certain types of hepatitis C infection without a need for interferon, the FDA said.
6 hrs ago | Examiner.com
A "game changing" new drug with an unprecedented 95% cure rate against the hepatitis C virus was approved by the U.S. Food and Drug Administration on December 6. "The future is looking very bright for people with hepatitis C," said Daniel Raymond, a consumer advocate and Policy Director at the Harm Reduction Coalition .
7 hrs ago | USA Today
Sovaldi, a new medication for hepatitis C that can be paired with other drugs to make treatment of the liver-damaging disease faster, easier and more effective, got approval from the Food and Drug Administration Friday.
8 hrs ago | Bradenton.com
The Food and Drug Administration approved the pill Sovaldi as a daily treatment in combination with older drugs to treat the major forms of hepatitis C. Current treatments for hepatitis C can take up to a year of therapy and only cure three out of four patients.
8 hrs ago | KNDU
Federal health officials have approved a highly anticipated hepatitis C drug from Gilead Sciences Inc. that is expected to offer a faster, more palatable cure to millions of people infected with the liver-destroying virus.
8 hrs ago | ClickOnDetroit
The U.S. Food and Drug Administration has approved a new drug called Sovaldi to treat chronic hepatitis C infections.
9 hrs ago | KFOR-TV Oklahoma City
Hepatitis C is a virus that has spread throughout the Baby Boomer population and nearly half of those infected don't know they were exposed to it decades ago.
11 hrs ago | The Winnipeg Free Press
So, you've decided to leave the snow and cold behind and spend a couple of weeks soaking up the tropical sun somewhere.
15 hrs ago | The Motley Fool
A new class of oral drugs for curing hepatits C is hitting the markets this winter, displacing injectible predecessors and ushering in treatments that are shorter and in some cases avoid side-affect riddled interferon.
16 hrs ago | PhysOrg Weblog
Multiple types of cells are needed for patients to recover from surgery or to restore life to tissues that have lost circulation.
20 hrs ago | GhanaWeb
On Tuesday, 3rd December, Ashesi's Leadership 4 class welcomed Ghanaian music icons Obour and Okyeame Kwame , President and Public Relations Officer of the Musicians Union of Ghana.
Liver cirrhosis is a chronic liver disease that destroys normal liver cells, replacing them with scar tissue.
Sometimes a drug comes along that's special enough to capture regulators attention before it's submitted for approval.
"The trainer sent me to the doctor to make sure I wasn't going to croak," Storch said.
The Food and Drug Administration is expected any day now to approve the first in a new class of drugs that can cure the leading cause of liver failure and liver cancer.
Summary "PharmaPoint: Hepatitis C Virus - Germany Drug Forecast and Market Analysis to 2022".